These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 17565859

  • 21. Expression of chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) in bladder transitional cell carcinoma.
    Ham WS, Lee JH, Yu HS, Choi YD.
    Urology; 2008 Oct; 72(4):921-6. PubMed ID: 18387660
    [Abstract] [Full Text] [Related]

  • 22. Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging.
    Ribal MJ, Mengual L, Marín M, Algaba F, Ars E, Fernández PL, Oliva R, Villavicencio H, Alcaraz A.
    Anticancer Res; 2006 Oct; 26(1A):411-9. PubMed ID: 16475726
    [Abstract] [Full Text] [Related]

  • 23. Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma.
    Rankin WV, Henry CJ, Turnquist SE, Turk JR, Beissenherz ME, Tyler JW, Rucker EB, Knapp DW, Rodriguez CO, Green JA.
    Vet Comp Oncol; 2008 Sep; 6(3):141-50. PubMed ID: 19178674
    [Abstract] [Full Text] [Related]

  • 24. p63 gene expression study and early bladder carcinogenesis.
    Compérat E, Bièche I, Dargère D, Ferlicot S, Laurendeau I, Benoît G, Vieillefond A, Verret C, Vidaud M, Capron F, Bedossa P, Paradis V.
    Urology; 2007 Sep; 70(3):459-62. PubMed ID: 17905096
    [Abstract] [Full Text] [Related]

  • 25. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S, Russo R, Ciancia G, Altieri V, De Rosa G, Insabato L.
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [Abstract] [Full Text] [Related]

  • 26. E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma.
    Shi B, Laudon V, Yu S, Dong D, Zhu Y, Xu Z.
    Urol Int; 2008 Jun; 81(3):320-4. PubMed ID: 18931551
    [Abstract] [Full Text] [Related]

  • 27. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
    Kunze E, Von Bonin F, Werner C, Wendt M, Schlott T.
    Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
    [Abstract] [Full Text] [Related]

  • 28. Expression and prognostic significance of Livin in the progression of bladder cancer.
    Zhu Z, Wang Y, Ding X, Zeng F, Xu K.
    J Huazhong Univ Sci Technolog Med Sci; 2008 Feb; 28(1):90-2. PubMed ID: 18278467
    [Abstract] [Full Text] [Related]

  • 29. Overexpression of HER-2/neu oncogene and transitional cell carcinoma of bladder.
    Jalali Nadoushan MR, Taheri T, Jouian N, Zaeri F.
    Urol J; 2007 Feb; 4(3):151-4. PubMed ID: 17987577
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of deleted in malignant brain tumors 1 (DMBT1) gene expression in bladder carcinoma cases: preliminary study.
    Dodurga Y, Avci CB, Yilmaz S, Dogan ZO, Kesen Z, Tataroglu C, Satiroglu-Tufan NL, Bushra T, Gunduz C.
    Biomarkers; 2011 Nov; 16(7):610-5. PubMed ID: 21999583
    [Abstract] [Full Text] [Related]

  • 31. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
    Nouraee N, Mowla SJ, Ozhand A, Parvin M, Ziaee SA, Hatefi N.
    Urol J; 2009 Nov; 6(2):101-8. PubMed ID: 19472128
    [Abstract] [Full Text] [Related]

  • 32. Suppression of livin gene expression by siRNA leads to growth inhibition and apoptosis induction in human bladder cancer T24 cells.
    Yang D, Song X, Zhang J, Ye L, Wang S, Che X, Wang J, Zhang Z, Wang L.
    Biosci Biotechnol Biochem; 2010 Nov; 74(5):1039-44. PubMed ID: 20460713
    [Abstract] [Full Text] [Related]

  • 33. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
    Catto JW, Azzouzi AR, Rehman I, Feeley KM, Cross SS, Amira N, Fromont G, Sibony M, Cussenot O, Meuth M, Hamdy FC.
    J Clin Oncol; 2005 May 01; 23(13):2903-10. PubMed ID: 15753461
    [Abstract] [Full Text] [Related]

  • 34. [Expression of SSX2 gene in human urologic neoplasms].
    Du P, Yu LZ, Ma M, Geng L, Wang XS, Xin DQ, Na YQ.
    Zhonghua Wai Ke Za Zhi; 2005 Mar 15; 43(6):379-81. PubMed ID: 15854347
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Expression of Caspase-3 and Bcl-2 in bladder transitional carcinoma and their significance].
    Shen HW, Yi L, Wang XM, Yao MJ, Deng JW, Fang JZ, Li MN.
    Ai Zheng; 2004 Feb 15; 23(2):181-4. PubMed ID: 14960240
    [Abstract] [Full Text] [Related]

  • 37. Expression and role of the inhibitor of apoptosis protein livin in chemotherapy sensitivity of ovarian carcinoma.
    Liu X, Wang A, Gao H, Yuan Z, Jiao Y.
    Int J Oncol; 2012 Sep 15; 41(3):1021-8. PubMed ID: 22766624
    [Abstract] [Full Text] [Related]

  • 38. Expression of MDR-1 gene in transitional cell carcinoma and its correlation with chemotherapy response.
    Pu YS, Tsai TC, Cheng AL, Tsai CY, Tseng NF, Su IJ, Hsieh CY, Lai MK.
    J Urol; 1996 Jul 15; 156(1):271-5. PubMed ID: 8648821
    [Abstract] [Full Text] [Related]

  • 39. [Expression of livin at the invasive tumor front of oral squamous cell carcinoma].
    Jiang L, Li X, Bai L, Zhang LJ, Zhang C.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun 15; 30(6):1398-400. PubMed ID: 20584688
    [Abstract] [Full Text] [Related]

  • 40. Differential expression of vascular endothelial growth factor165b in transitional cell carcinoma of the bladder.
    Das K, Zhao Y, Sugiono M, Lau W, Tan PH, Cheng C.
    Urol Oncol; 2007 Jun 15; 25(4):317-21. PubMed ID: 17628298
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.